Effector memory regulatory T-cell expansion marks a pivotal point of immune escape in myelodysplastic syndromes

Expansion of Effector Memory Regulatory T Cells Represents a Novel Prognostic Factor in Lower Risk Myelodysplastic Syndrome

(2012) A. W. Mailloux et al.   JOURNAL OF IMMUNOLOGY

Regulatory T cells in acute myelogenous leukemia: is it time for immunomodulation?

(2011) C. Ustun et al.   BLOOD

Immunologic Aspects of Hypoplastic Myelodysplastic Syndrome

(2011) Rodrigo T. Calado   SEMINARS IN ONCOLOGY

T-cell immune responses to Wilms tumor 1 protein in myelodysplasia responsive to immunosuppressive therapy

(2010) E. M. Sloand et al.   BLOOD

Immunosuppression for Myelodysplastic Syndrome: How Bench to Bedside to Bench Research Led to Success

(2010) Elaine M. Sloand et al.   HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA

Advancements in the molecular pathogenesis of myelodysplastic syndrome

(2009) Pearlie K Epling-Burnette et al.   CURRENT OPINION IN HEMATOLOGY

Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System

(2008) Hagop Kantarjian et al.   CANCER